CEL-SCI Corp CVM:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
1.36quote price arrow up+0.09 (+7.09%)
Volume
7,760,371
Close
1.27quote price arrow down-0.13 (-9.29%)
Volume
471,177
52 week range
1.04 - 3.23
Loading...
  • Open1.41
  • Day High1.41
  • Day Low1.25
  • Prev Close1.40
  • 52 Week High3.23
  • 52 Week High Date12/27/23
  • 52 Week Low1.04
  • 52 Week Low Date10/23/23

Key Stats

  • Market Cap68.554M
  • Shares Out53.98M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.06
  • YTD % Change-53.31

KEY STATS

  • Open1.41
  • Day High1.41
  • Day Low1.25
  • Prev Close1.40
  • 52 Week High3.23
  • 52 Week High Date12/27/23
  • 52 Week Low1.04
  • 52 Week Low Date10/23/23
  • Market Cap68.554M
  • Shares Out53.98M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.06
  • YTD % Change-53.31

RATIOS/PROFITABILITY

  • EPS (TTM)-0.63
  • P/E (TTM)-2.01
  • Fwd P/E (NTM)-3.34
  • EBITDA (TTM)-25.233M
  • ROE (TTM)-173.88%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-118,011.00%
  • Debt To Equity (MRQ)76.03%

EVENTS

  • Earnings Date08/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CEL-SCI Corp

 

Profile

MORE
CEL-SCI Corporation is a clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system. The Company is focused on the development of product candidates and technologies, such as Multikine, an investigational immunotherapy under development for the potential treatment of certain head and neck cancers, and Ligand Epitope Antigen Presentation System (LEAPS), with several...
Geert Kersten Esq.
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
Address
SUITE 802, 8229 BOONE BLVD .
Vienna, VA
22182
United States

Top Peers

SYMBOLLASTCHG%CHG
RLYB
Rallybio Corp
1.77-0.09-4.84%
CGTX
Cognition Therapeutics Inc
1.96+0.02+1.03%
ANEB
Anebulo Pharmaceuticals Inc
2.17-0.04-1.81%
SLS
Sellas Life Sciences Group Inc
1.46-0.01-0.68%
ALRN
Aileron Therapeutics Inc
3.77-0.08-2.08%